Current and historical daily PE Ratio for AVTX (
Avalo Therapeutics Inc
) from 2015 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Avalo Therapeutics stock (AVTX) PE ratio as of Apr 24 2024 is 0.
More Details
Avalo Therapeutics Inc (AVTX) PE Ratio (TTM) Chart
Avalo Therapeutics Inc (AVTX) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Avalo Therapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-04-24 | At Loss | 2024-02-20 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
2024-04-12 | At Loss | 2024-02-07 | At Loss |
2024-04-11 | At Loss | 2024-02-06 | At Loss |
2024-04-10 | At Loss | 2024-02-05 | At Loss |
2024-04-09 | At Loss | 2024-02-02 | At Loss |
2024-04-08 | At Loss | 2024-02-01 | At Loss |
2024-04-05 | At Loss | 2024-01-31 | At Loss |
2024-04-04 | At Loss | 2024-01-30 | At Loss |
2024-04-03 | At Loss | 2024-01-29 | At Loss |
2024-04-02 | At Loss | 2024-01-26 | At Loss |
2024-04-01 | At Loss | 2024-01-25 | At Loss |
2024-03-28 | At Loss | 2024-01-24 | At Loss |
2024-03-27 | At Loss | 2024-01-23 | At Loss |
2024-03-26 | At Loss | 2024-01-22 | At Loss |
2024-03-25 | At Loss | 2024-01-19 | At Loss |
2024-03-22 | At Loss | 2024-01-18 | At Loss |
2024-03-21 | At Loss | 2024-01-17 | At Loss |
2024-03-20 | At Loss | 2024-01-16 | At Loss |
2024-03-19 | At Loss | 2024-01-12 | At Loss |
2024-03-18 | At Loss | 2024-01-11 | At Loss |
2024-03-15 | At Loss | 2024-01-10 | At Loss |
2024-03-14 | At Loss | 2024-01-09 | At Loss |
2024-03-13 | At Loss | 2024-01-08 | At Loss |
2024-03-12 | At Loss | 2024-01-05 | At Loss |
2024-03-11 | At Loss | 2024-01-04 | At Loss |
2024-03-08 | At Loss | 2024-01-03 | At Loss |
2024-03-07 | At Loss | 2024-01-02 | At Loss |
2024-03-06 | At Loss | 2023-12-29 | At Loss |
2024-03-05 | At Loss | 2023-12-28 | At Loss |
2024-03-04 | At Loss | 2023-12-27 | At Loss |
2024-03-01 | At Loss | 2023-12-26 | At Loss |
2024-02-29 | At Loss | 2023-12-22 | At Loss |
2024-02-28 | At Loss | 2023-12-21 | At Loss |
2024-02-27 | At Loss | 2023-12-20 | At Loss |
2024-02-26 | At Loss | 2023-12-19 | At Loss |
2024-02-23 | At Loss | 2023-12-18 | At Loss |
2024-02-22 | At Loss | 2023-12-15 | At Loss |
2024-02-21 | At Loss | 2023-12-14 | At Loss |
Avalo Therapeutics Inc (AVTX) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Avalo Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US15671L1098
Description